ArticlePharmaceutics2023

Chitosan-Based Nanoparticles for Targeted Nasal Galantamine Delivery as a Promising Tool in Alzheimer's Disease Therapy.

Dilyana Georgieva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.